Large-scale testing (Phase 3)Looking for participantsNCT07776509
What this trial is testing
Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Who this might be right for
Obesity or OverweightWeight-Related ComorbidityWith/Without Diabetes Mellitus, Type 2
AstraZeneca 500